Equities

Kalbe Farma Tbk PT

Kalbe Farma Tbk PT

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (IDR)1,600.00
  • Today's Change10.00 / 0.63%
  • Shares traded27.95m
  • 1 Year change+0.63%
  • Beta0.4047
Data delayed at least 10 minutes, as of Nov 05 2024 09:09 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Tuesday, Kalbe Farma Tbk PT (KLBF:JKT) closed at 1,600.00, -10.86% below its 52-week high of 1,795.00, set on Aug 28, 2024.
52-week range
Today
1,375.00Apr 19 20241,795.00Aug 28 2024
Open1,605.00
High1,620.00
Low1,590.00
Bid1,600.00
Offer1,610.00
Previous close1,590.00
Average volume27.70m
Shares outstanding46.88bn
Free float19.67bn
P/E (TTM)23.82
Market cap74.53tn IDR
EPS (TTM)66.76
IDR
Annual div (ADY)31.00
IDR
Annual div yield (ADY)1.95%
Div ex-dateMay 29 2024
Div pay-dateJun 14 2024
Data delayed at least 10 minutes, as of Nov 05 2024 09:09 GMT.
More ▼

Events & Activity

  • KLBF:JKT price rises above 200-day moving average to 1,585.00 at 02:04 GMT
  • KLBF:JKT price rises above 200-day moving average to 1,580.00 at 20:59 GMT
  • KLBF:JKT price moved over -1.24% to 1,595.00
  • KLBF:JKT price falls below 200-day moving average to 1,570.00 at 03:00 BST
  • KLBF:JKT price falls below 200-day moving average to 1,570.00 at 23:20 BST
  • KLBF:JKT trading volume exceeds daily average by +15.16%
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.